Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- betibeglogene autotemcel
- Telzir (fosamprenavir)
Interactions between your drugs
fosamprenavir betibeglogene autotemcel
Applies to: Telzir (fosamprenavir), betibeglogene autotemcel
Fosamprenavir may interfere with the process used to make betibeglogene autotemcel from your own blood cells. The makers of betibeglogene autotemcel recommend that fosamprenavir be stopped before your blood stem cells are collected. You should speak with your doctor to ensure that fosamprenavir is stopped at the appropriate time. Betibeglogene autotemcel may also interfere with the results of certain types of laboratory tests. Be sure to speak with the laboratory or your healthcare provider if you need to be screened for certain types of viruses, like human immunodeficiency virus (HIV), to ensure that treatment with betibeglogene autotemcel does not interfere with the test. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
fosamprenavir food
Applies to: Telzir (fosamprenavir)
Fosamprenavir suspension should be administered on an empty stomach in adults, but with food in pediatric patients to help the taste and compliance. If vomiting occurs within 30 minutes after dosing the suspension, the dose should be repeated. Fosamprenavir tablets may be taken with or without food. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Reblozyl
Reblozyl is used to treat anemia in adults with beta-thalassemia or myelodysplastic syndromes ...
Zynteglo
Zynteglo (betibeglogene autotemcel) is a gene therapy indicated for the treatment of patients with ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.